Dectrekumab (Anti-IL-13)
Dectrekumab (Anti-IL-13) (A2950-GRP)
Products
Description
Dectrekumab (anti-IL-13) is a humanized monoclonal antibody that targets interleukin-13 (IL-13). It has the potential to be used in inflammation and immunology-related research. MW: 146.16 KD.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Manufacturer Cat# | A2950 |
| Target | Interleukins |